ATE48616T1 - Analoge von hypokalzemischen polypeptiden, welche den kalziumgehalt des koerpers schonen, deren herstellung, deren verwendung als arznei und diese enthaltende zusammensetzungen. - Google Patents

Analoge von hypokalzemischen polypeptiden, welche den kalziumgehalt des koerpers schonen, deren herstellung, deren verwendung als arznei und diese enthaltende zusammensetzungen.

Info

Publication number
ATE48616T1
ATE48616T1 AT86402871T AT86402871T ATE48616T1 AT E48616 T1 ATE48616 T1 AT E48616T1 AT 86402871 T AT86402871 T AT 86402871T AT 86402871 T AT86402871 T AT 86402871T AT E48616 T1 ATE48616 T1 AT E48616T1
Authority
AT
Austria
Prior art keywords
hypocalcemic
analogues
polypeptides
compositions containing
conserve
Prior art date
Application number
AT86402871T
Other languages
English (en)
Inventor
Gerard Milhaud
Original Assignee
Gerard Milhaud
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gerard Milhaud filed Critical Gerard Milhaud
Application granted granted Critical
Publication of ATE48616T1 publication Critical patent/ATE48616T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/585Calcitonins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Purification Treatments By Anaerobic Or Anaerobic And Aerobic Bacteria Or Animals (AREA)
AT86402871T 1985-12-24 1986-12-19 Analoge von hypokalzemischen polypeptiden, welche den kalziumgehalt des koerpers schonen, deren herstellung, deren verwendung als arznei und diese enthaltende zusammensetzungen. ATE48616T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8519113A FR2592049B1 (fr) 1985-12-24 1985-12-24 Nouveaux analogues de composes polypeptidiques hypocalcemiants epargnant le calcium de l'organisme, leur preparation et les medicaments contenant ces principes actifs
EP86402871A EP0232650B1 (de) 1985-12-24 1986-12-19 Analoge von hypokalzemischen Polypeptiden, welche den Kalziumgehalt des Körpers schonen, deren Herstellung, deren Verwendung als Arznei und diese enthaltende Zusammensetzungen

Publications (1)

Publication Number Publication Date
ATE48616T1 true ATE48616T1 (de) 1989-12-15

Family

ID=9326119

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86402871T ATE48616T1 (de) 1985-12-24 1986-12-19 Analoge von hypokalzemischen polypeptiden, welche den kalziumgehalt des koerpers schonen, deren herstellung, deren verwendung als arznei und diese enthaltende zusammensetzungen.

Country Status (13)

Country Link
EP (1) EP0232650B1 (de)
JP (1) JPH0813838B2 (de)
AT (1) ATE48616T1 (de)
CA (1) CA1273750A (de)
DE (1) DE3667472D1 (de)
DK (1) DK436187A (de)
ES (1) ES2012456B3 (de)
FI (1) FI87795C (de)
FR (1) FR2592049B1 (de)
GR (1) GR3000279T3 (de)
IE (1) IE59489B1 (de)
PT (1) PT84011B (de)
WO (1) WO1987003884A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991007433A1 (en) * 1989-11-08 1991-05-30 Daicel Chemical Industries, Ltd. Peptide and process for preparing cyclic peptide
US5364840A (en) * 1989-12-05 1994-11-15 Vical, Inc. Synthetic calcitonin peptides
ES2055665B1 (es) * 1993-02-03 1995-03-01 Lipotec Sa Procedimiento para la obtencion de carbocalcitonina.
US5962270A (en) 1996-02-06 1999-10-05 Bionebraska, Inc. Recombinant preparation of calcitonin fragments and use thereof in the preparation of calcitonin and related analogs

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS51128993A (en) * 1975-05-01 1976-11-10 Tanpakushitsu Kenkyu Shiyoureikai Process for preparing new polypeptides
US4401593A (en) * 1982-02-12 1983-08-30 Armour Pharmaceutical Company Glycine - 8 calcitonin
US4537716A (en) * 1983-12-05 1985-08-27 Armour Pharmaceutical Co. Des-serine2 or des-glycine2 -leucine22 calcitonin
JPS60123500A (ja) * 1983-12-08 1985-07-02 Mitsubishi Petrochem Co Ltd 新規カルシトニン及びその採取法
US4528132A (en) * 1984-01-13 1985-07-09 Armour Pharmaceutical Company [16-Alanine]calcitonin
JPS61112099A (ja) * 1984-11-06 1986-05-30 Mitsubishi Petrochem Co Ltd 新規ポリペプチド及びその製造法

Also Published As

Publication number Publication date
DK436187A (da) 1987-10-23
FR2592049B1 (fr) 1988-02-12
GR3000279T3 (en) 1991-03-15
DK436187D0 (da) 1987-08-21
EP0232650A1 (de) 1987-08-19
CA1273750A (fr) 1990-09-04
FI873632L (fi) 1987-08-21
DE3667472D1 (de) 1990-01-18
FI87795C (fi) 1993-02-25
JPH0813838B2 (ja) 1996-02-14
FR2592049A1 (fr) 1987-06-26
IE863386L (en) 1987-06-24
FI873632A0 (fi) 1987-08-21
EP0232650B1 (de) 1989-12-13
WO1987003884A1 (fr) 1987-07-02
PT84011A (fr) 1987-01-01
PT84011B (pt) 1989-07-31
JPS63502343A (ja) 1988-09-08
IE59489B1 (en) 1994-03-09
FI87795B (fi) 1992-11-13
ES2012456B3 (es) 1990-04-01

Similar Documents

Publication Publication Date Title
YU47800B (sr) Estri tienil-karboksilne kiseline sa aminoalkoholima, njihova kvaterna jedinjenja kao i pripremanje tih jedinjenja
ES536909A0 (es) Procedimiento para la preparacion de compuestos complejos de piroxicam con ciclodestrinas
FI870219A0 (fi) Hypoglykemiska tiazolidindioner.
ATE56728T1 (de) Neue polypeptide mit alpha-amylase-hemmender wirkung, verfahren zu deren herstellung, deren verwendung und pharmazeutische praeparate.
FI854227A0 (fi) Menetelmä analgeettisena aineena käyttökelpoisten polypeptidien valmistamiseksi
ZA881067B (en) Production of proteins in active forms
DE59208974D1 (de) Neue pyrazinderivative, ihre herstellung und verwendung
DE69130497D1 (de) Neue Verwendung von 1-Alpha-hydroxylierten-19-nor-vitamin-D-Verbindungen zur Behandlung von Psoriasis
ES2092868T3 (es) Utilizacion de derivados de la 4-tiorresorcina en unas composiciones cosmeticas o dermofarmaceuticas de accion despigmentante.
DK0401896T3 (da) Carboplatinmateriale
ATE48616T1 (de) Analoge von hypokalzemischen polypeptiden, welche den kalziumgehalt des koerpers schonen, deren herstellung, deren verwendung als arznei und diese enthaltende zusammensetzungen.
NO180636C (no) Fremgangsmåte for fremstilling av et rent O-glycosylert IGF-1
UA42722C2 (uk) Сульфіди, сульфоксиди або сульфони, або їх фармацевтично прийнятні солі і фармацевтична композиція, що їх містить
ES2059403T3 (es) Composicion util en el tratamiento de deficiencias de estrogenos.
GR3002825T3 (en) Pharmaceutical composition consisting of a calcium carbonate suspension
DK162839C (da) N,3-diacyl-2-oxindol-1-carboxamid-forbindelser og 3-acyl-2-oxindol-forbindelser til anvendelse som mellemprodukter ved deres fremstilling
BR8700698A (pt) Composicao fungicida e composicao de protecao de madeira,a base de sal de morfolina substituida com acido fluoborico
ATE24716T1 (de) Lenkotrien-antagonisten.
DK43891D0 (da) Pentapeptid og fremgangsmaade til fremstilling deraf
DE3768640D1 (de) Kautschukmischungen, welche amino-derivate von 1,3,4-thiadiazol enthalten.
DE3672635D1 (de) Esterderivate von 2,2-dimethyl-3-ethenylcyclopropancarbonsaeure, ihre herstellung, ihre verwendung als parasitizide und sie enthaltende zusammensetzungen.
DE3478745D1 (en) 6h-dibenz (b,e)(1,4)oxathiepin compounds
GT198900051A (es) Derivados de aminoacidos.
ES286561U (es) Envase perfeccionado
KR890001530A (ko) 지방산과 염기성 아미노산 혼합물의 생체 에너지원 대체

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee